|
Dr. Wyeth Wasserman: Dr. Wasserman is a Professor at the University of British Columbia and senior scientist at the Centre for Molecular Medicine and Therapeutics (CMMT). Prior to this, he worked with GlaxoSmithKline Inc. and Pharmacia Corp. (since acquired by Pfizer Inc.), and is world renowned for his ground breaking research in the identification of key functional regions in the Human Genome. Dr. Wasserman leads the field in the development of bioinformatics tools used to discover the on/off switches for human genes. These genetic switches, called transcription factor binding sites, are the control points that define when and where each gene will be active. An individual with genetic abnormalities at these key points in their genome may be susceptible to various forms of disease or may be overly responsive or non-responsive to certain drugs. | 